Grant Opportunity For Postdoctoral IBD Researchers
Three exceptional postdoctoral researchers will each receive a $300,000 grant, awarded over two years, to support their innovative biomedical research relevant to IBD.
Three exceptional postdoctoral researchers will each receive a $300,000 grant, awarded over two years, to support their innovative biomedical research relevant to IBD.
Explore highlights from our conversation with Steve Axelrod, PhD, President and CEO at G-Tech Medical, which has developed a non-invasive technology to monitor gut motility.
Explore highlights from our conversation with Julie Saiki, PhD, of Azora Therapeutics, a clinical-stage biopharmaceutical company developing an alternative to immuno-suppressive therapies.
Highlights from our conversation with Gary Mathias of Thetis Pharmaceuticals, a clinical-stage biopharmaceutical company developing alternatives to immuno-suppressive therapies.
The Foundation announced the promotion of Lorena Gomez-Barris to a newly created role, Director of Administration and Workplace Experience
The 2026 Symposium will be held in San Francisco on July 19-21, convening researchers, clinicians and trainees working across disciplines to accelerate progress in preventing and treating IBD.
The Rainin Foundation has compiled resources to help our grantees manage the evolving landscape and continue their vital work.
Shelley Trott, Executive Director, shares how the moment we are in sets the stage for a “Third Founding” that centers human dignity, agency and possibility.
The Foundation’s $4 million Response Fund allowed for nimble, timely and strategic giving as we galvanized to support our communities and protect and defend human rights.
SFFILM announced the recipients of the 2025 SFFILM Rainin Grant and the 2025 SFFILM Rainin Filmmakers with Disabilities Grant.